GB2046734B - 7-(-oximino-pyrazolyl(-acetamido)-cephen derivatives - Google Patents
7-(-oximino-pyrazolyl(-acetamido)-cephen derivativesInfo
- Publication number
- GB2046734B GB2046734B GB8004696A GB8004696A GB2046734B GB 2046734 B GB2046734 B GB 2046734B GB 8004696 A GB8004696 A GB 8004696A GB 8004696 A GB8004696 A GB 8004696A GB 2046734 B GB2046734 B GB 2046734B
- Authority
- GB
- United Kingdom
- Prior art keywords
- cephen
- oximino
- acetamido
- pyrazolyl
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
- C07D231/40—Acylated on said nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH154579A CH641810A5 (en) | 1979-02-16 | 1979-02-16 | Acetamidocephalosporanic acid derivatives, process for their preparation and pharmaceutical forms which contain them |
| CH17480A CH645378A5 (en) | 1980-01-10 | 1980-01-10 | Acetamidocephalosporanic acid derivatives, process for their preparation and pharmaceutical forms which contain them |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| GB2046734A GB2046734A (en) | 1980-11-19 |
| GB2046734B true GB2046734B (en) | 1983-09-01 |
Family
ID=25683752
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB8004696A Expired GB2046734B (en) | 1979-02-16 | 1980-02-12 | 7-(-oximino-pyrazolyl(-acetamido)-cephen derivatives |
| GB08309730A Expired GB2117774B (en) | 1979-02-16 | 1983-04-11 | Oximinoacetic acid derivatives |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB08309730A Expired GB2117774B (en) | 1979-02-16 | 1983-04-11 | Oximinoacetic acid derivatives |
Country Status (19)
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CY1365A (en) * | 1980-03-28 | 1987-08-07 | Biochemie Gmbh | New process for the production of cephalosporin antibiotics, and novel intermediates used in such process and their production |
| CH648038A5 (de) * | 1981-01-19 | 1985-02-28 | Sandoz Ag | 7-((carboxymethoxyimino)-1h-pyrazol-3-yl-acetyl)amino-3-desacetoxy-3-(1-methyl-1h-tetrazol-5-yl-thio)cephalosporansaeure und salze, verfahren zur herstellung und verwendung. |
| GB2125033B (en) * | 1982-07-23 | 1985-08-29 | Servipharm Ltd | Cephalosporins |
| US4698338A (en) * | 1986-02-19 | 1987-10-06 | Eli Lilly And Company | 7[2-(2-aminothiazol-4-yl)-2-benzyloximino]acetamido-3[4-alkyl-5-oxo-6-hydroxy-3,4-dihydro-1,2,4-triazin-3-yl]thiomethyl cephalosporins |
| US5688964A (en) * | 1996-02-13 | 1997-11-18 | Eastman Kodak Company | Process for preparing a acylhyrazino pyrazole derivative |
| AU7319100A (en) * | 1999-09-24 | 2001-04-24 | Agro-Kanesho Co. Ltd. | Insecticidal and acaricidal agents |
| DE60234057D1 (de) | 2001-07-25 | 2009-11-26 | Raptor Pharmaceutical Inc | Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke |
| EP1889198B1 (en) | 2005-04-28 | 2014-11-26 | Proteus Digital Health, Inc. | Pharma-informatics system |
| WO2008036682A2 (en) | 2006-09-18 | 2008-03-27 | Raptor Pharmaceutical Inc. | Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates |
| DK3395372T3 (da) | 2009-02-20 | 2022-04-19 | Enhanx Biopharm Inc | System til afgivelse af glutathion-baseret medikament |
| EP2427178B1 (en) | 2009-05-06 | 2023-01-04 | Laboratory Skin Care, Inc. | Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same |
| US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4024137A (en) * | 1971-05-14 | 1977-05-17 | Glaxo Laboratories Limited | 7β-[2-Etherified oximino-2-(phenyl- or naphthylacetamido)] cephalosporins |
-
1980
- 1980-02-07 SE SE8000982A patent/SE8000982L/xx not_active Application Discontinuation
- 1980-02-07 DK DK53780A patent/DK53780A/da not_active Application Discontinuation
- 1980-02-07 FI FI800381A patent/FI800381A/fi not_active Application Discontinuation
- 1980-02-11 DE DE19803005012 patent/DE3005012A1/de not_active Withdrawn
- 1980-02-12 GB GB8004696A patent/GB2046734B/en not_active Expired
- 1980-02-13 NL NL8000894A patent/NL8000894A/nl not_active Application Discontinuation
- 1980-02-13 FR FR8003143A patent/FR2449093A1/fr active Granted
- 1980-02-14 IL IL59391A patent/IL59391A/xx unknown
- 1980-02-14 NZ NZ192873A patent/NZ192873A/en unknown
- 1980-02-14 PT PT70834A patent/PT70834A/pt unknown
- 1980-02-14 AT AT0078780A patent/AT374806B/de not_active IP Right Cessation
- 1980-02-14 YU YU00402/80A patent/YU40280A/xx unknown
- 1980-02-14 IE IE284/80A patent/IE49395B1/en unknown
- 1980-02-14 CA CA000345659A patent/CA1161032A/en not_active Expired
- 1980-02-15 PH PH23650A patent/PH17926A/en unknown
- 1980-02-15 IT IT8047922A patent/IT8047922A0/it unknown
- 1980-02-15 ES ES488651A patent/ES8102134A1/es not_active Expired
- 1980-11-20 ES ES497002A patent/ES8203848A1/es not_active Expired
-
1982
- 1982-06-21 US US06/390,323 patent/US4477448A/en not_active Expired - Fee Related
-
1983
- 1983-04-11 GB GB08309730A patent/GB2117774B/en not_active Expired
-
1985
- 1985-02-08 SE SE8500589A patent/SE8500589D0/xx unknown
- 1985-12-30 MY MY128/85A patent/MY8500128A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MY8500128A (en) | 1985-12-31 |
| GB2117774B (en) | 1984-03-21 |
| GB2046734A (en) | 1980-11-19 |
| DK53780A (da) | 1980-08-17 |
| FR2449093B1 (US06244707-20010612-C00011.png) | 1983-07-29 |
| ES497002A0 (es) | 1982-04-01 |
| IE49395B1 (en) | 1985-10-02 |
| SE8500589D0 (sv) | 1985-02-08 |
| NZ192873A (en) | 1984-07-31 |
| IT8047922A0 (it) | 1980-02-15 |
| ES488651A0 (es) | 1980-12-16 |
| GB8309730D0 (en) | 1983-05-18 |
| NL8000894A (nl) | 1980-08-19 |
| ATA78780A (de) | 1983-10-15 |
| SE8000982L (sv) | 1980-08-17 |
| IL59391A (en) | 1983-05-15 |
| AT374806B (de) | 1984-06-12 |
| GB2117774A (en) | 1983-10-19 |
| PH17926A (en) | 1985-01-31 |
| US4477448A (en) | 1984-10-16 |
| CA1161032A (en) | 1984-01-24 |
| FR2449093A1 (fr) | 1980-09-12 |
| ES8203848A1 (es) | 1982-04-01 |
| FI800381A (fi) | 1980-08-17 |
| PT70834A (en) | 1980-03-01 |
| IE800284L (en) | 1980-08-16 |
| DE3005012A1 (de) | 1980-11-27 |
| YU40280A (en) | 1983-06-30 |
| IL59391A0 (en) | 1980-05-30 |
| ES8102134A1 (es) | 1980-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2055813B (en) | Aminoalkylbenzene derivatives | |
| GB2054560B (en) | Benzylimdiazole derivatives | |
| GB2058765B (en) | Deformyltylosin derivatives | |
| NZ193800A (en) | 3-vinylcephalosporin derivatives | |
| PH15946A (en) | 3-vinyl-cephalosporin derivatives | |
| GB2046734B (en) | 7-(-oximino-pyrazolyl(-acetamido)-cephen derivatives | |
| GB2055818B (en) | 3-methyleneazetidine derivatives | |
| GB2056452B (en) | Halovincamone derivatives | |
| CU35300A (en) | Pyrrholidine derivatives | |
| GB2065111B (en) | Decaprenylamine derivatives | |
| GB2052493B (en) | Imidazobenzodiazepine derivatives | |
| GB2053899B (en) | Terahydrophthalamide derivatives | |
| GB2062464B (en) | Eburnamenine derivatives | |
| GB2055368B (en) | E-homoeburnane derivatives | |
| PH15098A (en) | 15-sulfonamidoprostaglandin derivatives | |
| HK55483A (en) | Isopropylamino-pyrimidine derivatives | |
| GB2050377B (en) | Pyrazinoquinoxaline derivatives | |
| GB2043064B (en) | Oximidazoquinoxaline derivatives | |
| GB2059954B (en) | 1-phenethylimidazole derivatives | |
| GB2065110B (en) | Decaprenylamine derivatives | |
| GB2065109B (en) | Decaprenylamine derivatives | |
| GB2042508B (en) | 3-alkoxy-penem derivatives | |
| GB2045234B (en) | Anilionotropone derivatives | |
| GB2122600B (en) | Hexahydronaphthacene derivatives | |
| GB2122186B (en) | Oxapenem derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PCNP | Patent ceased through non-payment of renewal fee |